Tech Company Financing Transactions
Form Bio Funding Round
Form Bio closed a $30 million funding round on 9/27/2022. Investors included JAZZ Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
9/27/2022
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
JAZZ Venture Partners (Lead Investor) (John Spinale)
private investors (Thomas Tull)
Proceeds Purpose
Form Bio's technology can be used for more than the de-extinction practices, such as drug discovery, gene and cell therapy, manufacturing efficiency and academic research.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1401 Lavaca Street Unit number 155
Austin, TX 78701
USA
Austin, TX 78701
USA
Phone
Undisclosed
Website
Email Address
Overview
Incubated and spun out of Colossal Biosciences in 2022, Form Bio was developed to empower scientific discovery. Our mission is to help scientists reach their next breakthroughs faster and with less effort. To fulfill our mission, we're bringing together world class software professionals, life scientists and data scientists. Interested in joining our mission and our team? Learn about Careers at Form Bio.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andrew Busey
Chief Marketing Officer
Adam Weinroth
Co-Founder
Ben Lamm
Co-Founder
Kent Wakeford
Browse more venture capital transactions:
Prev: 9/27/2022: Avidbots venture capital transaction
Next: 9/27/2022: Sinai Technologies venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs